BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36863793)

  • 21. Epigenetic regulation and T-cell responses in endometriosis - something other than autoimmunity.
    Szukiewicz D
    Front Immunol; 2022; 13():943839. PubMed ID: 35935991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
    Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
    Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone receptor modulators for endometriosis.
    Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology of endometriosis: from aromatase to genomic abnormalities.
    Bulun SE; Monsivais D; Kakinuma T; Furukawa Y; Bernardi L; Pavone ME; Dyson M
    Semin Reprod Med; 2015 May; 33(3):220-4. PubMed ID: 26036904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dual inhibition of AKT and ERK1/2 pathways on endometrial pro-inflammatory, hormonal, and epigenetic microenvironment in endometriosis.
    Arosh JA; Lee J; Banu SK
    Mol Cell Endocrinol; 2022 Jan; 539():111446. PubMed ID: 34478807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered gene expression of VEGF, IGFs and H19 lncRNA and epigenetic profile of H19-DMR region in endometrial tissues of women with endometriosis.
    Kamrani S; Amirchaghmaghi E; Ghaffari F; Shahhoseini M; Ghaedi K
    Reprod Health; 2022 Apr; 19(1):100. PubMed ID: 35459174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis.
    García-Gómez E; Vázquez-Martínez ER; Reyes-Mayoral C; Cruz-Orozco OP; Camacho-Arroyo I; Cerbón M
    Front Endocrinol (Lausanne); 2019; 10():935. PubMed ID: 32063886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis.
    Houshdaran S; Nezhat CR; Vo KC; Zelenko Z; Irwin JC; Giudice LC
    Biol Reprod; 2016 Nov; 95(5):93. PubMed ID: 27535958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endometriosis and genetics: what responsibility for the genes?].
    Borghese B; Vaiman D; de Ziegler D; Chapron C
    J Gynecol Obstet Biol Reprod (Paris); 2010 May; 39(3):196-207. PubMed ID: 20399038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.
    Han SJ; O'Malley BW
    Hum Reprod Update; 2014; 20(4):467-84. PubMed ID: 24634322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone Actions and Resistance in Gynecological Disorders.
    MacLean JA; Hayashi K
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study.
    Fujishita A; Nakane PK; Koji T; Masuzaki H; Chavez RO; Yamabe T; Ishimaru T
    Fertil Steril; 1997 May; 67(5):856-64. PubMed ID: 9130890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells.
    Arosh JA; Lee J; Starzinski-Powitz A; Banu SK
    Mol Cell Endocrinol; 2015 Jul; 409():51-8. PubMed ID: 25843056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target.
    Nasu K; Kawano Y; Tsukamoto Y; Takano M; Takai N; Li H; Furukawa Y; Abe W; Moriyama M; Narahara H
    J Obstet Gynaecol Res; 2011 Jul; 37(7):683-95. PubMed ID: 21651673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis.
    Wu Y; Strawn E; Basir Z; Halverson G; Guo SW
    Epigenetics; 2006; 1(2):106-11. PubMed ID: 17965625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis.
    Pluchino N; Mamillapalli R; Wenger JM; Ramyead L; Drakopoulos P; Tille JC; Taylor HS
    Fertil Steril; 2020 Jun; 113(6):1224-1231.e1. PubMed ID: 32416979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis.
    Chwalisz K; Garg R; Brenner RM; Schubert G; Elger W
    Ann N Y Acad Sci; 2002 Mar; 955():373-88; discussion 389-93, 396-406. PubMed ID: 11949964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heme induced progesterone-resistant profiling and promotion of endometriosis in vitro and in vivo.
    Ma XQ; Liu YY; Zhong ZQ; Chen SM; Hu WT; Sheng YR; Liu YK; Wei CY; Li MQ; Zhu XY
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166761. PubMed ID: 37247698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic aberration of gene expression in endometriosis.
    Izawa M; Taniguchi F; Terakawa N; Harada T
    Front Biosci (Elite Ed); 2013 Jun; 5(3):900-10. PubMed ID: 23747905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.